S Clift

4.9k citations

30 papers · 3.7k indexed · 1 hit paper · h-index 25

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Molecular Biology 19
- Biochemical and Molecular Research 7
- RNA Interference and Gene Delivery 4
Genetics 14
- Virus-based gene therapy research 8
- Animal Genetics and Reproduction 6

Co-authors: Ronald M. Krauss (2 shared papers)Edward M. Rubin (3 shared papers)Elizabeth A. Spangler (2 shared papers)Judy G. Verstuyft (1 shared paper)David W. Martin (6 shared papers)L. Cohen (6 shared papers)Lorraine J. Gudas (7 shared papers)E M Rubin (1 shared paper)
Journals: Journal of Biological Chemistry (6 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Investigation (2 papers)Nature (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Netherlands Sweden

In The Last Decade

S Clift

30 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI 1991 · 820 citations

Peers

Countries citing papers authored by S Clift

Since Specialization

Citations

This map shows the geographic impact of S Clift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Clift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Clift more than expected).

Fields of papers citing papers by S Clift

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Clift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Clift. The network helps show where S Clift may publish in the future.

Co-authors

The 25 scholars most cited alongside S Clift, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S Clift Line = papers co-authored together S Clift links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI Nature ·Edward M. Rubin, Ronald M. Krauss, Elizabeth A. Spangler, Judy G. Verstuyft, S Clift Hit paper breakdown →	1991	820
2	Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. PubMed ·Jonathan W. Simons, Bahar Mikhak, Ju-Fay Chang, Angelo M. De Marzo, Michael A. Carducci, Michael Lim, Christine E. Weber, Angelo A. Baccala, Marti Goemann, S Clift, Dale Ando, Hyam I. Levitsky, L. Cohen, Martin G. Sanda, Richard C. Mulligan, Alan W. Partin, H. Ballentine B Carter, Steven Piantadosi, Fray F. Marshall, William G. Nelson	1999	375
3	Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer The Journal of Urology ·J.W. Simons, Elizabeth M. Jaffee, C. Weber, Hy Levitsky, William G. Nelson, Michael A. Carducci, A Lazenby, L. Cohen, C. C. Finn, S Clift, Karen M. Hauda, Lisa A. Beck, Kristin M. Leiferman, Albert H. Owens, Steven Piantadosi, Glen Dranoff, Richard Mulligan, Drew M. Pardoll, Fray F. Marshall	1998	329
4	Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. Journal of Clinical Investigation ·Joyce Carlson, Brianne B. Rogers, R N Sifers, Milton J. Finegold, S Clift, Francesco J. DeMayo, David W. Bullock, Savio L.C. Woo	1989	243
5	Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proceedings of the National Academy of Sciences ·E M Rubin, Brian Y. Ishida, S Clift, Ronald M. Krauss	1991	242
6	Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma Journal of Clinical Oncology ·Robert J. Soiffer, F. Stephen Hodi, Frank G. Haluska, Ken Jung, Silke Gillessen, Samuel Singer, Kenneth K. Tanabe, Rosemary B. Duda, Steven J. Mentzer, Michael T. Jaklitsch, Raphael Bueno, S Clift, Steve Hardy, Donna Neuberg, Richard C. Mulligan, Iain J. Webb, Martín C. Mihm, Glenn Dranoff	2003	225
7	Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: Genetic model for immunodeficiency disease Proceedings of the National Academy of Sciences ·Buddy Ullman, Lorraine J. Gudas, S Clift, David W. Martin	1979	136
8	X–chromosome inactivation during differentiation of female teratocarcinoma stem cells in vitro Nature ·Gail R. Martin, Charles J. Epstein, Bruce Travis, Georgianne Tucker, S Yatziv, David W. Martin, S Clift, Sara Cohen	1978	116
9	The rat casein multigene family. Fine structure and evolution of the beta-casein gene. Journal of Biological Chemistry ·William K. Jones, Li‐Yuan Yu‐Lee, S Clift, Terry L. Brown, Jeffrey M. Rosen	1985	108
10	Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice Nucleic Acids Research ·Richard N. Sifers, Joyce Carlson, S Clift, Francesco J. DeMayo, David W. Bullock, Savio L.C. Woo	1987	105
11	Phase I/II Trial of an Allogeneic Cellular Immunotherapy in Hormone-Naive Prostate Cancer Clinical Cancer Research ·Jonathan W. Simons, Michael A. Carducci, Bahar Mikhak, Michael Lim, Barbara Biedrzycki, Flavia Borellini, S Clift, Kristen Hege, Dale Ando, Steven Piantadosi, Richard C. Mulligan, William G. Nelson	2006	100
12	Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proceedings of the National Academy of Sciences ·Varavani Dwarki, Paula Belloni, Tarlochan Nijjar, Jonathan D. Smith, Lizette Couto, M Rabier, S Clift, A. Berns, L. Cohen	1995	94
13	High efficiency gene transfer into primary human tumor explants without cell selection. PubMed ·Elizabeth M. Jaffee, Glenn Dranoff, L. Cohen, Karen M. Hauda, S Clift, Fray F. Marshall, Richard C. Mulligan, Drew M. Pardoll	1993	94
14	Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. Journal of Biological Chemistry ·Joshua R. Schultz, Enhao Gong, M R McCall, Alex V. Nichols, S Clift, Edward M. Rubin	1992	91
15	Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With AutologousGM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients Journal of Clinical Oncology ·Rosalie M. Luiten, Esther W. M. Kueter, Wolter J. Mooi, M.P.W. Gallee, Elaine M. Rankin, Winald R. Gerritsen, S Clift, Willem J. Nooijen, P. Weder, Willeke F. van de Kasteele, Johan Sein, Paul C.M. van den Berk, Omgo E. Nieweg, Anton Berns, Hergen Spits, Gijsbert C. de Gast	2005	90
16	Phase I Study of Non-Replicating Autologous Tumor Cell Injections Using Cells Prepared With or Without GM-CSF Gene Transduction in Patients with Metastatic Renal Cell Carcinoma. Johns Hopkins Oncology Center, Baltimore, Maryland Human Gene Therapy ·Anton Berns, S Clift, L. Cohen, Ross C. Donehower, Glenn Dranoff, Karen M. Hauda, Elizabeth M. Jaffee, Audrey J. Lazenby, Hyam I. Levitsky, Fray F. Marshall, Richard C. Mulligan, William G. Nelson, Albert H. Owens, Drew M. Pardoll, Gordon Parry, Alan H. Partin, Steven Piantadosi, Jonathan W. Simons, James Zabora	1995	64
17	Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies Cancer Chemotherapy and Pharmacology ·William G. Nelson, Jonathan W. Simons, Bahar Mikhak, Ju-Fay Chang, Angelo M. De Marzo, Michael A. Carducci, Michael Kim, Christine E. Weber, Angelo A. Baccala, Marti A. Goeman, S Clift, Dale Ando, Hyam I. Levitsky, L. Cohen, Martin G. Sanda, Richard C. Mulligan, Alan W. Partin, H. Ballentine Carter, Steven Piantadosi, Fray F. Marshall	2000	62
18	Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer The Journal of Urology ·J.W. Simons, Elizabeth M. Jaffee, Christine E. Weber, H.J. Levitsky, William G. Nelson, Michael A. Carducci, A Lazenby, Laura K. Cohen, C. C. Finn, S Clift, Karen M. Hauda, Lisa A. Beck, K M Leiferman, Albert H. Owens, Steven Piantadosi, Glenn Dranoff, Richard C. Mulligan, Drew M. Pardoll, Fray F. Marshall	1998	61
19	Alterations in deoxyribonucleotide metabolism in cultured cells with ribonucleotide reductase activities refractory to feedback inhibition by 2'-deoxyadenosine triphosphate. Journal of Biological Chemistry ·Buddy Ullman, S Clift, Lorraine J. Gudas, Barbara Levinson, M. A. Wormsted, David W. Martin	1980	58
20	Hypoxia-induced in vivo sickling of transgenic mouse red cells. Journal of Clinical Investigation ·Edward M. Rubin, H. Ewa Witkowska, Elizabeth A. Spangler, Peter Curtin, Bertram H. Lubin, Narla Mohandas, S Clift	1991	49

About S Clift

S Clift is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Infectious Diseases, having authored 30 papers that have together received 3.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (7 papers), Biochemical and Molecular Research (7 papers), Animal Genetics and Reproduction (6 papers), RNA Interference and Gene Delivery (4 papers), HIV/AIDS drug development and treatment (4 papers) and Adenosine and Purinergic Signaling (3 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.1k citations), Endocrinology, Diabetes and Metabolism (546 citations), Genetics (843 citations) and Cancer Research (407 citations). S Clift has collaborated with scholars based in United States, Netherlands and Sweden. Frequent co-authors include Ronald M. Krauss, Edward M. Rubin, Elizabeth A. Spangler, Judy G. Verstuyft, David W. Martin, L. Cohen, Lorraine J. Gudas, E M Rubin, Brian Y. Ishida and Richard C. Mulligan. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation, Nature and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact